Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Personalized ovarian cancer treatment.
Rodriguez AO.
Curr Opin Obstet Gynecol. 2012 Feb;24(1):1-2. No abstract available.
Related citations
Bevacizumab and ovarian cancer.
Sato S, Itamochi H.
Curr Opin Obstet Gynecol. 2012 Feb;24(1):8-13. Review.
Minimally invasive gynecologic procedures.
Donnez J, Squifflet J, Donnez O.
Curr Opin Obstet Gynecol. 2011 Aug;23(4):289-95. Review.
The utility of proteomics in gynecologic cancers.
Van Gorp T, Cadron I, Vergote I.
Curr Opin Obstet Gynecol. 2011 Feb;23(1):3-7. Review.
'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis.
Liu N, Wang X, Sheng X.
Curr Opin Obstet Gynecol. 2011 Feb;23(1):19-23. Review.
Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy.
Tsujioka H, Yotsumoto F, Hikita S, Ueda T, Kuroki M, Miyamoto S.
Curr Opin Obstet Gynecol. 2011 Feb;23(1):24-30. Review.
Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer.
Ino K.
Curr Opin Obstet Gynecol. 2011 Feb;23(1):13-8. Review.
Borderline ovarian tumors and fertility.
Nam JH.
Curr Opin Obstet Gynecol. 2010 Jun;22(3):227-34. Review.
Strategies in the histologic diagnosis of low-grade glandular endometrial neoplasm.
Izadi-Mood N, Sarmadi S, Sanii S.
Curr Opin Obstet Gynecol. 2010 Feb;22(1):43-50. Review.
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications.
Kurian AW.
Curr Opin Obstet Gynecol. 2010 Feb;22(1):72-8. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on